CME Group (CME) to Release Earnings on Wednesday

CME Group (NASDAQ:CME) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, October 23rd. Analysts expect CME Group to post earnings of $2.48 per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter in the prior year, the firm earned $2.30 EPS. The business’s revenue for the quarter was up 12.7% compared to the same quarter last year. On average, analysts expect CME Group to post $10 EPS for the current fiscal year and $10 EPS for the next fiscal year.

CME Group Stock Down 0.6 %

Shares of NASDAQ CME opened at $227.05 on Tuesday. CME Group has a one year low of $190.70 and a one year high of $230.12. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The business’s fifty day moving average price is $217.33 and its 200-day moving average price is $208.42. The stock has a market capitalization of $81.75 billion, a PE ratio of 25.83, a P/E/G ratio of 7.76 and a beta of 0.55.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were issued a dividend of $1.15 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.03%. CME Group’s dividend payout ratio (DPR) is 52.33%.

Insiders Place Their Bets

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CME. Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a report on Tuesday, October 8th. Oppenheimer upped their target price on CME Group from $228.00 to $245.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Morgan Stanley upped their target price on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. Bank of America upped their target price on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research note on Thursday, October 3rd. Finally, TD Cowen initiated coverage on CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price on the stock. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $220.07.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.